Stocks and Investing Stocks and Investing
Wed, September 18, 2024

Eliana Merle Maintained (BNTX) at Hold with Increased Target to $131 on, Sep 18th, 2024


Published on 2024-10-28 14:19:24 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $97 to $131 on, Sep 18th, 2024.

Eliana has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 2 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


These are the ratings of the 4 analyists that currently disagree with Eliana


  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $150 on, Tuesday, September 17th, 2024
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
  • Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024
Contributing Sources